|
Volumn 20, Issue 9, 1999, Pages 429-439
|
Pharmacokinetics of ezlopitant, a novel non-peptidic neurokinin-1 receptor antagonist in preclinical species and metabolite kinetics of the pharmacologically active metabolites
|
Author keywords
Active metabolites; Cerebrospinal fluid; Ezlopitant; NK 1 antagonist; Pharmacokinetics
|
Indexed keywords
2 DIPHENYLMETHYL 3 (5 ISOPROPYL 2 METHOXY BENZYLAMINO)1 AZABICYCLO[2.2.2]OCTANE;
CJ 12458;
CJ 12764;
EZLOPITANT;
NEUROKININ 1 RECEPTOR ANTAGONIST;
UNCLASSIFIED DRUG;
ANIMAL CELL;
ANIMAL TISSUE;
ARTICLE;
CONTROLLED STUDY;
DRUG CLEARANCE;
DRUG METABOLISM;
DRUG RECEPTOR BINDING;
DRUG STRUCTURE;
FEMALE;
FERRET;
GERBIL;
GUINEA PIG;
LIVER BLOOD FLOW;
MALE;
NONHUMAN;
RAT;
STEADY STATE;
|
EID: 0033864633
PISSN: 01422782
EISSN: None
Source Type: Journal
DOI: 10.1002/1099-081X(199912)20:9<429::AID-BDD209>3.0.CO;2-D Document Type: Article |
Times cited : (20)
|
References (11)
|